21 CFR § 524.1312 Ophthalmic and Topical Dosage Form New Animal Drugs

§ 524.1312 Marbofloxacin, terbinafine, and dexamethasone otic suspension.

Current through Sep 8, 2026 · Read all of Part 524

(a) Specifications. Each single-use tube contains 15.1 milligrams (mg) marbofloxacin, 22.7 mg terbinafine, and 2.01 mg dexamethasone.

(b) Sponsor. See No. 043264 in § 510.600(c) of this chapter.

(c) Conditions of use—(1) Amount. Administer one dose (1 tube) per affected ear once. Do not clean the ear canal for 30 days after administration.

(2) Indications for use. For the treatment of otitis externa associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius) in dogs.

(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

[90 FR 40970, Aug. 22, 2025]

← § 524.1240 Levamisole.§ 524.1376 2-Mercaptobenzothiazole solution. →